Jong-Jing Wang

Title: Jong-Jing Wang: Innovator in Oral Drug Delivery Systems

Introduction

Jong-Jing Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of oral drug delivery systems. His innovative approach addresses the challenges associated with administering unstable or poorly-absorbed drugs.

Latest Patents

Wang holds a patent for the invention titled "Oral administration of unstable or poorly-absorbed drugs." This patent focuses on dosage forms and combinations that facilitate effective oral administration of drugs that are typically unsuitable for this route due to degradation caused by acid and digestive enzymes. The invention includes a self-microemulsifying drug delivery system (SMEDDS) that, when co-administered with an antacid, can prevent drug degradation and enhance absorption in the gastrointestinal tract. This technology is particularly beneficial for administering insulin orally, allowing for long-term storage and reconstitution before use.

Career Highlights

Wang is currently associated with Innopharmax, Inc., where he continues to develop innovative solutions in drug delivery. His work has the potential to revolutionize how certain medications are administered, improving patient compliance and therapeutic outcomes.

Collaborations

Wang collaborates with talented colleagues, including Yu-Tsai Yang and Pei-Jing Hsu, who contribute to the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Jong-Jing Wang's contributions to oral drug delivery systems exemplify the impact of innovation in the pharmaceutical industry. His work not only addresses critical challenges but also paves the way for more effective treatment options for patients.